Drug Database
Back to search

Ireland· IE-PA-EU/1/15/1002/001

LENVIMA 4 mg hard capsules

A other antineoplastic agents product containing lenvatinib mesylate, registered in Ireland by Eisai GmbH. The same ATC class is registered in 5 of our 19 countries.

ATC L01X

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedLENVIMA 4 mg hard capsulesATCL01XREGISTER NO.IE-PA-EU/1/15/1002/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lenvatinib mesylateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lenvatinib mesylate is registered in 5 of 19 countries.

Countries holding a registration under ATC L01X (other antineoplastic agents), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search lenvatinib mesylate products by name

Lenvatinib mesylate · ATC L01X

5 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Lenvatinib mesylate
Manufacturer
Eisai GmbH
Country
Ireland (IE)
ATC code
L01X
ATC class
OTHER ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/15/1002/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lenvatinib mesylate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenvatinib mesylate products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Lenvatinib Accord, Lenvatinib Rcc Sandoz
  • Belgium · Ixedafin, Lenvatinib Accord
  • Bulgaria · Ленватиниб Виатрис
  • Cyprus · Lenvatinib Remedica
  • Czechia · Lenvatinib Accord, Lenvatinib Sandoz
  • Germany · Lenvatinib Accord, Lenvatinib Hexal
  • Denmark · Lenvatinib Accord, Lenvatinib Sandoz
  • Estonia · Lenvatinib Remedica, Lenvatinib Sandoz
  • Spain · Lenvatinib Accord, Lenvatinib Sandoz
  • Finland · Ixedafin, Lenvatinib
  • France · Lenvatinib Accord, Lenvatinib Biogaran
  • United Kingdom (Northern Ireland) · Lenvatinib, Lenvatinib Thornton & Ross
  • Greece · Kynvalib, Lenvatinib Elpen
  • Croatia · Lenvatinib Remedica
  • Hungary · Lenvatinib Stada
  • Iceland · Kisplyx, Lenvima
  • Italy · Lenvatinib Accord, Lenvatinib Sandoz
  • Liechtenstein · Kisplyx, Lenvima
  • Lithuania · Lenvatinib Sandoz, Lenvatinib Stada
  • Luxembourg · Ixedafin, Lenvatinib Olpha
  • Latvia · Lenvatinib Sandoz, Lenvatinib Stada
  • Malta · Lenvatinib Remedica, Lenvatinib Stada
  • Netherlands · Lenvatinib 1a Pharma, Lenvatinib Accord
  • Norway · Kisplyx, Lenvatinib Accord
  • Portugal · Lenvatinib Accord, Lenvatinib Sandoz
  • Sweden · Lenvatinib Accord, Lenvatinib Avansor
  • Slovenia · 10 Mg, Lenvatinib Sandoz
  • Slovakia · Lenvatinib Pharmevid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59dbce8f-a81f-46d2-8a7b-a8b096e275d4
GET /v1/drugs/59dbce8f-a81f-46d2-8a7b-a8b096e275d4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01X"
  ],
  "strength": null,
  "pa_number": "EU/1/15/1002/001",
  "substances": [
    "Lenvatinib mesylate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "28/05/2015",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about lenvatinib mesylate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console